SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Human & Experimental Toxicology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Palmen, N.G.M.
Right arrow Articles by Henderson, P.Th.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Palmen, N.G.M.
Right arrow Articles by Henderson, P.Th.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CIMETIDINE
*N,N-DIMETHYLACETAMIDE
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Toxicokinetics of Dimethylacetamide (DMAc) in Rat Isolated Perfused Liver

N.G.M. Palmen

Department of Pharmacology, Toxicology Section, University of Limburg, PO Box 616, 6200 MD Maastricht

C.T.A. Evelo

Department of Pharmacology, Toxicology Section, University of Limburg, PO Box 616, 6200 MD Maastricht

P.J.A. Borm

Department of Occupational Medicine, University of Limburg, PO Box 616, 6200 MD Maastricht

P.Th. Henderson

TNO Medical Biological Laboratory, PO Box 45, 2288 AA Rijswijk, The Netherlands

Dimethylacetamide (DMAc) is a skin-penetrating solvent able to induce hepatic damage after chronic exposure. Previous research has indicated that metabolism may be saturated at its present TLV/TWA (10 ppm). Biological monitoring of monomethylacetamide (MMAc), the primary metabolite of DMAc, might therefore underestimate exposure to DMAC and related health hazards. We used the recirculating perfusion technique in isolated rat liver to evaluate DMAC metabolism. Medium concentrations starting at about 30, 50, 100 and 275 µM, respectively, were tested. Perfusate samples were taken regularly and analysed for DMAc; pharmacokinetic parameters (extraction ratio and clearance) were calculated for each perfusion. Inlet DMAc concentrations were calculated and concentration groups divided in 16, 36, 70, 160, 225 µM. The extraction ratio of the 16 µm group differed significantly from the other concentration groups tested. DMAc metabolism was saturated at a DMAc concentration of 36 µM. Extraction ratios were unaffected when cimetidine, an inhibitor of cytochrome P450 activity, was added to the perfusion medium or when cimetidine-pretreated animals were used. DMAc clearance was 2.20 ml min-1 at a medium concentration of about 36 µM. Extrapolation of the observed (rat) liver clearance to man showed that airborne concentrations of 18 ppm would, under the presumptions used, lead to saturated metabolism of DMAc; however, saturation at even lower concentrations could not be excluded.

Human & Experimental Toxicology, Vol. 12, No. 2, 127-133 (1993)
DOI: 10.1177/096032719301200206


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement